Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.96.20 CHF
Change Today +0.40 / 0.42%
Volume 4.3M
As of 12:43 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph Jimenez MBA

Chief Executive Officer, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 7 board members in 2 different organizations across 17 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Joseph Jimenez, also known as Joe, MBA serves as Chief Executive Officer of Novartis Vaccines and Diagnostics, Inc. Mr. Jimenez has been the Chief Executive Officer of Novartis AG since February 1, 2010. Mr. Jimenez serves as the Chief Executive Officer of Novartis International AG. He served as the Chief Executive of Global Pharmaceuticals Business at Novartis Pharmaceuticals Corporation (Novartis Corporation). He served as the Chief Executive Officer of Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056


Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Former Director and Member of Compensation Committee
Vice President of the Board
Former Director
Former Director
Former Director and Member of Compensation Committee
Former Non-Executive Director, Member of Remuneration Committee and Member of Nomination Committee
Chairman of the Board
Former Independent Director, Member of Nominating & Corporate Governance Committee and Member of Finance Committee


BA 1982
Stanford University
MBA 1984
University of California Berkeley

Other Affiliations*

Annual Compensation*

Total Annual CompensationSFr.6,078,584

Stock Options*

Long Term Incentive PlanSFr.6,181,504
All Other CompensationSFr.388,402
Total Number of Options157,266

Total Compensation*

Total Annual Cash CompensationSFr.6,466,986
Total Short Term CompensationSFr.6,078,584
Other Long Term CompensationSFr.388,402
Total Calculated CompensationSFr.12,648,490
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.96.20 CHF +0.40


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at